retatrutide parkinson's disease trial GLP-1 Agonists: A New Frontier in Treatment? parkinson's disease retatrutide clinical trial

Manejo del estrs mediante tcnicas de relajacin, meditacin, o yoga puede beneficiar la funcin intestinal, ya que el eje cerebro-intestino influye significativamente en la motilidad

All treatments require an individualized medical evaluation

However, physiological levels of cortisol do not induce mineralocorticoid effects because 11-hydroxysteroid dehydrogenase type 2 (11-HSD2) inactivates cortisol into cortisone in tissues with high MR expression (1)

Expecting a single drug to meaningfully alter the course of Alzheimers once cognitive decline is underway is an extraordinarily high bar. However, Kaeberlein believed there may still be hope